Blog
Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
EQS-News: Deutsche Rohstoff AG: On track for record production in 2023 after first quarter
EQS-News: Deutsche Rohstoff AG: On track for record production in 2023 after first quarter
EQS-News: Enapter AG starts deliveries of first water-cooled AEM Electrolyser EL 4.0s
EQS-News: Enapter AG starts deliveries of first water-cooled AEM Electrolyser EL 4.0s
Hardman & Co Research on Chesnara plc (CSN): Great cash flow in tough markets
Hardman & Co Research on Chesnara plc (CSN): Great cash flow in tough markets
EQS-News: DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS
EQS-News: DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS
Cairn Homes Plc Transaction in Own Shares
Cairn Homes Plc Transaction in Own Shares
RM plc: Holding(s) in Company
RM plc: Holding(s) in Company
EQS-News: SMT Scharf AG reports significant revenue and earnings growth in 2022
EQS-News: SMT Scharf AG reports significant revenue and earnings growth in 2022
Orascom Development Holding AG: Publication of the 2022 Annual Report
Orascom Development Holding AG: Publication of the 2022 Annual Report
Leclanché SA Introduces New Circular Economy 6R Concept in Line with New EU Regulations
Leclanché SA Introduces New Circular Economy 6R Concept in Line with New EU Regulations
EQS-Adhoc: Adtran Holdings, Inc.:
EQS-Adhoc: Adtran Holdings, Inc.:
MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary
MD Medical Group Investments Plc: MD Medical Group launches the procedure for changing the GDR program depositary
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Evotec SE provides update on cyber attack
EQS-News: Evotec SE provides update on cyber attack
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-News: Mainz Biomed Provides Full Year 2022 Financial Results
EQS-News: Mainz Biomed Provides Full Year 2022 Financial Results
Turkiye Garanti Bankasi A.S.: Coupon payment of Subordinated Debt Securities to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Subordinated Debt Securities to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
EQS-Adhoc: Cyber Attack on Evotec
EQS-Adhoc: Cyber Attack on Evotec
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
BROADPEAK SA: Broadpeak is launching a new CDN solution offering unparalleled technological and ecological performance
BROADPEAK SA: Broadpeak is launching a new CDN solution offering unparalleled technological and ecological performance
Lepermislibre: 2022 full-year results and Q1 2023 revenue
Lepermislibre: 2022 full-year results and Q1 2023 revenue


